Jacobs Levy Equity Management’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-17,447
| Closed | -$1M | – | 1085 |
|
|
2022
Q1 | $1M | Buy |
17,447
+11,683
| +203% | +$672K | 0.01% | 753 |
|
|
2021
Q4 | $684K | Buy |
+5,764
| New | +$684K | ﹤0.01% | 792 |
|
|
2021
Q3 | – | Sell |
-2,372
| Closed | -$413K | – | 1126 |
|
|
2021
Q2 | $413K | Sell |
2,372
-5,205
| -69% | -$906K | ﹤0.01% | 899 |
|
|
2021
Q1 | $1.5M | Buy |
7,577
+2,926
| +63% | +$579K | 0.01% | 651 |
|
|
2020
Q4 | $915K | Sell |
4,651
-5,008
| -52% | -$985K | 0.01% | 744 |
|
|
2020
Q3 | $1.71M | Buy |
+9,659
| New | +$1.71M | 0.02% | 547 |
|
|
2020
Q2 | – | Sell |
-1,596
| Closed | -$186K | – | 1151 |
|
|
2020
Q1 | $186K | Buy |
+1,596
| New | +$186K | ﹤0.01% | 897 |
|
|
2019
Q3 | – | Sell |
-1,914
| Closed | -$328K | – | 995 |
|
|
2019
Q2 | $328K | Buy |
+1,914
| New | +$328K | ﹤0.01% | 804 |
|
|
2018
Q3 | – | Sell |
-535
| Closed | -$142K | – | 1069 |
|
|
2018
Q2 | $142K | Buy |
+535
| New | +$142K | ﹤0.01% | 980 |
|
|
2018
Q1 | – | Sell |
-628
| Closed | -$85K | – | 1061 |
|
|
2017
Q4 | $85K | Buy |
+628
| New | +$85K | ﹤0.01% | 958 |
|